Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Acta Neuropathologica

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 17653558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GM1 specifically interacts with alpha-synuclein and inhibits fibrillation.

  2007cited by this paper
• Neuron-specific nuclear antigen NeuN is not detectable in gerbil subtantia nigra pars reticulata.

  2007cited by this paper
• Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration

  2006cited by this paper
• Mechanisms of Neuronal Death in Synucleinopathy

  2006cited by this paper
• The role of alpha-synuclein in the pathogenesis of multiple system atrophy.

  2005cited by this paper
• Histochemical features of stress-induced aggregates in alpha-synuclein overexpressing cells.

  2004cited by this paper
• Neuropathology provides clues to the pathophysiology of Gaucher disease.

  2004cited by this paper
• Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease.

  2004cited by this paper
• Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses.

  2004cited by this paper
• The cell biology of lysosomal storage disorders

  2004cited by this paper
• The role of alpha-synuclein in both neuroprotection and neurodegeneration.

  2004cited by this paper
• Neuropathological findings of an autopsy case of adult β-galactosidase and neuraminidase deficiency

  2004cited by this paper
• Lipid binding inhibits alpha-synuclein fibril formation.

  2003cited by this paper
• The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease.

  2003cited by this paper
• Distribution of α‐ and γ‐synucleins in the adult rat brain and their modification by high‐dose cocaine treatment

  2003cited by this paper
• Accumulation of phosphorylated alpha-synuclein in aging human brain.

  2003cited by this paper
• Neuronal accumulation of alpha- and beta-synucleins in the brain of a GM2 gangliosidosis mouse model.

  2003cited by this paper
• Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.

  2002cited by this paper
• Alpha-synuclein-immunoreactive deposits in human and animal prion diseases

  2002cited by this paper
• Frequency and distribution of TUNEL‐positive neurons in brains of dementia with Lewy bodies: Comparison with those in brains of Alzheimer's disease

  2001cited by this paper
• Alpha-synuclein and neurodegenerative diseases

  2001cited by this paper
• beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor.

  2001cited by this paper
• Occurrence of human alpha-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer's disease.

  2000cited by this paper
• Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

  1998cited by this paper
• Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein

  1998cited by this paper
• Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein

  1998cited by this paper
• Lysosomal and Peroxisomal Disorders. Recent Advances: Introduction

  1998cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders

  1997cited by this paper
• Immunohistochemical investigation of human leukocyte antigen (HLA)-DR-positive astrocytes in adrenoleukodystrophy brain.

  1996cited by this paper
• Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

  1993cited by this paper
• Neuronal ubiquitin and neurofilament expression in different lysosomal storage disorders.

  1992cited by this paper
• SANDHOFF DISEASE

  1981cited by this paper
• [Lipoidosis--with special reference to metachromatic leucodystrophy and Tay-Sachs disease].

  1967cited by this paper

• Sphingolipidoses: expanding the spectrum of α-synucleinopathies.

  2025cites this paper
• Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies

  2024cites this paper
• Role of Lipids in the Pathogenesis of Parkinson’s Disease

  2024cites this paper
• Seed-competent α-synuclein pathology in metachromatic leukodystrophy: the expanding spectrum of α-synucleinopathy in sphingolipidoses

  2024cites this paper
• Association of rare variants in ARSA with Parkinson’s disease

  2023cites this paper
• Association of Rare Variants in ARSA with Parkinson's Disease

  2023cites this paper
• Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson’s Disease

  2022cites this paper
• From lysosomal storage disorders to Parkinson's Disease - Challenges and opportunities.

  2022cites this paper
• Upstream lipid and metabolic systems are potential causes of Alzheimer's disease, Parkinson's disease and dementias

  2022cites this paper
• Evidence of seeding capacity of α-synuclein assemblies in infantile Krabbe disease.

  2022cites this paper
• Extracellular alpha-synuclein: Sensors, receptors, and responses.

  2022cites this paper
• β-Synuclein: An Enigmatic Protein with Diverse Functionality

  2022cites this paper
• Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia

  2021cites this paper
• Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease

  2021cites this paper
• Neurodegenerative Disease Risk in Carriers of Autosomal Recessive Disease

  2021cites this paper
• Insights into Lewy body disease from rare neurometabolic disorders

  2021cites this paper
• Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids

  2021cites this paper
• Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders

  2021cites this paper
• Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease

  2020cites this paper
• Peroxisomal Dysfunction and Oxidative Stress in Neurodegenerative Disease: A Bidirectional Crosstalk.

  2020cites this paper
• When lipid homeostasis runs havoc: lipotoxicity links lysosomal dysfunction to autophagy.

  2020cites this paper
• The Emerging Role of the Lysosome in Parkinson’s Disease

  2020cites this paper
• Glycosphingolipids and neuroinflammation in Parkinson’s disease

  2020cites this paper
• Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential

  2020cites this paper
• Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity

  2020cites this paper
• LRRK2-Related Parkinson’s Disease Due to Altered Endolysosomal Biology With Variable Lewy Body Pathology: A Hypothesis

  2020cites this paper
• Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson’s Disease

  2020cites this paper
• Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.

  2019cites this paper
• The Role of Lipids in Parkinson’s Disease

  2019cites this paper
• Modeling neuronopathic storage diseases with patient-derived culture systems.

  2019cites this paper
• Emerging links between pediatric lysosomal storage diseases and adult parkinsonism

  2019cites this paper
• Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease

  2019cites this paper
• Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease

  2019cites this paper
• Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease

  2019cites this paper
• Novel Results and Concepts Emerging From Lipid Cell Biology Relevant to Degenerative Brain Aging and Disease

  2019cites this paper
• The Vicious Cycle Between α‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction

  2019cites this paper
• Impaired Cargo Clearance in the Retinal Pigment Epithelium (RPE) Underlies Irreversible Blinding Diseases

  2018cites this paper
• Genetics and Therapies for GM2 Gangliosidosis

  2018cites this paper
• Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patients

  2017cites this paper
• Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders.

  2017cites this paper
• Accumulated α-synuclein affects the progression of GM2 gangliosidoses.

  2016cites this paper
• Membrane lipids as therapeutic targets for Parkinson’s disease: a possible link between Lewy pathology and membrane lipids

  2016cites this paper
• From rare to common and back again: 60years of lysosomal dysfunction.

  2016cites this paper
• Gene-Wise Association of Variants in Four Lysosomal Storage Disorder Genes in Neuropathologically Confirmed Lewy Body Disease

  2015cites this paper
• The endosomal pathway in Parkinson's disease.

  2015cites this paper
• Glucocerebrosidase deficiency accelerates the accumulation of proteinase K-resistant α-synuclein and aggravates neurodegeneration in a Drosophila model of Parkinson's disease.

  2015cites this paper
• Genetic Convergence of Parkinson’s Disease and Lysosomal Storage Disorders

  2014cites this paper
• Neuronal inclusions of α‐synuclein contribute to the pathogenesis of Krabbe disease

  2014influential citation
• Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease

  2014cites this paper
• Niemann‐Pick disease type C1 predominantly involving the frontotemporal region, with cortical and brainstem Lewy bodies: An autopsy case

  2014cites this paper
• Impairment of homeostasis in lysosomal storage disorders

  2014cites this paper
• Arylsulphatase A activity in familial parkinsonism: a pathogenetic role?

  2014cites this paper
• Neuronopathic lysosomal storage diseases: clinical and pathologic findings.

  2013cites this paper
• The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction.

  2012cites this paper
• Lysosomal storage disorders: The cellular impact of lysosomal dysfunction

  2012cites this paper
• Lysosome‐dependent pathways as a unifying theme in Parkinson's disease

  2012cites this paper
• The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders

  2012cites this paper
• Gangliosides as a Double-Edged Swordin Neurodegenerative Disease

  2011influential citation
• Genetic analysis of lysosomal alpha-galactosidase A gene in sporadic Parkinson's disease.

  2011cites this paper
• Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond

  2011influential citation
• Decreased Expression of Lysosomal Alpha-Galactosiase A Gene in Sporadic Parkinson’s Disease

  2011cites this paper
• Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease

  2010cites this paper
• IDS crossing of the blood-brain barrier corrects CNS defects in MPSII mice.

  2009cites this paper
• Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo

  2009cites this paper
• Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies.

  2009cites this paper
• Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein

  2009cites this paper
• α‐Synuclein abnormalities in mouse models of peroxisome biogenesis disorders

  2009cites this paper
• Neural Stem Cell Transplantation Benefits a Monogenic Neurometabolic Disorder During the Symptomatic Phase of Disease

  2009cites this paper
• Identification of new markers for neurodegeneration process in the mouse model of Sly disease as revealed by expression profiling of selected genes

  2008cites this paper
• Molecular and cellular biology of synucleins.

  2008cites this paper
• Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity

  2008cites this paper
• Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue

  2008cites this paper
• Cathepsin D Expression Level Affects Alpha-synuclein Processing, Aggregation, and Toxicity in Vivo Cathepsin D Expression Level Affects Alpha-synuclein Processing, Aggregation, and Toxicity in Vivo

  year unknowncites this paper